Non-dilutive Funding Focus Leverage The Conafay Group's proven track record of helping clients secure nearly $1B in non-dilutive funding to position as a strategic partner for life sciences companies seeking grant, contract, and public funding opportunities.

Federal and Public Policy Expertise Target life science firms aiming to influence health policy, federal grants, and public-private partnerships, highlighting TCG’s strength in federal government relations and coalition management to accelerate market access.

Integrated Stakeholder Network Highlight ability to bridge relationships with philanthropic, academic, nonprofit, and commercial entities to unlock partnerships and funding, presenting cross-sector collaboration as a unique value proposition.

Specialized Life Sciences Focus Position as a niche advisory with deep biomedical technology and therapeutics experience, enabling tailored funding strategies and policy advocacy that align with client R&D timelines and regulatory considerations.

Small Firm Agility Emphasize intimate team composition and founder-led leadership under Stephen Conafay to offer personalized service, rapid responsiveness, and a competitive alternative to larger firms for mid-market life sciences targets.